The medical conference model, like everything else, is changing due to COVID.
Researchers are experimenting with nanobots in healthcare to perform complicated medical practices with unprecedented levels of precision.
The convergence has happened because digital health technologies are making it easier for biopharmaceutical companies to discover, develop and launch new drugs faster and cheaper and improve the patient and doctor experience, in what is being labeled "after the pill".
My first reaction to the COVID pandemic, actually just months but seemingly lifetimes ago, was not about social determinants of health.
Sickcare entrepreneurs face many hurdles trying to navigate the innovation roadmap.
You probably have heard about the relationship between mindfulness and relaxation but that's not all it does.
Tracking the pandemic trends- from around the U.S. and throughout the world- as best I can (no one can hope to keep up entirely with the constant deluge of data, drama, dogma, and diatribe)- I incline toward the hope that COVID may be offering us a Mulligan.